Publication:
5-Flourouracil-Induced Encephalopathy in Parkinson's Disease

Simple item page
dc.contributor.authorDANE, FAYSAL
dc.contributor.authorYUMUK, PERRAN FULDEN
dc.contributor.authorsKorkmaz, Taner; Seber, Selcuk; Basaran, Gul; Yumuk, P. Fulden; Dane, Faysal; Kocar, Muharrem; Telli, Ferhat; Turhal, N. Serdar
dc.date.accessioned2022-03-14T10:07:02Z
dc.date.accessioned2026-01-11T06:23:22Z
dc.date.available2022-03-14T10:07:02Z
dc.date.issued2012-03-31
dc.description.abstractA 59 year-old male with Parkinson's disease developed encephalopathy during adjuvant treatment of rectal cancer. Acute neurotoxicity related to high dose 5-Flourouracil infusion is well described, but encephalopathy with low dose bolus 5-Flourouracil is rare. The advanced Parkinson's disease patients may be more prone to hyperammonemia associated encephalopathy caused by 5-Flourouracil. The prompt recognition of the symptoms is key to diagnosis and treatment.
dc.identifier.doi10.4999/uhod.10041
dc.identifier.issn1306-133X
dc.identifier.urihttps://hdl.handle.net/11424/244069
dc.identifier.wosWOS:000302826900009
dc.language.isoeng
dc.publisherAKAD DOKTORLAR YAYINEVI
dc.relation.ispartofUHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectParkinson's disease
dc.subject5-Flourouracil
dc.subjectRectum cancer
dc.subjectEncephalopathy
dc.subjectNEUROTOXICITY
dc.subject5-FLUOROURACIL
dc.subjectFLUOROURACIL
dc.subjectINFUSION
dc.title5-Flourouracil-Induced Encephalopathy in Parkinson's Disease
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage53
oaire.citation.issue1
oaire.citation.startPage51
oaire.citation.titleUHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
oaire.citation.volume22

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
file.pdf
Size:
439.15 KB
Format:
Adobe Portable Document Format
Download

Collections

Araştırma Çıktıları